Both Carnitine and Creatine work to optimize energy during workouts, help delay fatigue, and aid in faster recovery
GLP-1 and dual GIP/GLP-1 receptor agonists such as Wegovy, Ozempic, Saxenda, Mounjaro, and ZepBound work at the hormonal level to regulate appetite, slow gastric emptying, improve satiety, and stabilize blood sugar
Incorporating biologics and additional OSA treatments could improve patient identification accuracy
The clinical reasons are weight loss plateau, comorbidity benefit not achieved on tirzepatide, or interest in retatrutides larger weight loss magnitude
Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction